Prediction of lymph node metastasis by p53, p21Waf1, and PCNA expression in esophageal cancer patients

Journal of Experimental and Clinical Cancer Research

Volumn 22, Issue 2, 2003, Pages 239-245

  Ueno, Hideiki ^a   Hirai, T ^a   Nishimoto, N ^a   Hihara, J ^a   Inoue, H ^a   Yoshida, K ^a   Yamashita, Y ^a   Toge, T ^a   Tsubota, N ^b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Labour Welfare Corporation   (Japan)

Author keywords

Esophageal cancer; Lymph node metastasis; p21waf1; p53; PCNA; Quantification theory II; Submucosal invasion

Indexed keywords

CYCLINE; PROTEIN P21; PROTEIN P53;

ANTIGEN DETECTION; ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; GENE EXPRESSION; GENETIC MARKER; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; TUMOR LOCALIZATION;

CARCINOMA; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC MARKERS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MUCOUS MEMBRANE; PROLIFERATING CELL NUCLEAR ANTIGEN; RISK; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0038037946     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Gunderson L.L., Haddock N.G., Goldenberg R., Burch P., Trastek V., Donohue J., Nelson H.: Alimentary cancer. In: Philip Rubin, ed 8th edition, Clinical Oncology, 2001: 685-98
2. Udagawa H., Akiyama H.: Surgical treatment of esophageal cancer: Tokyo experience of three-field technique. Dis. Esophagus. 14: 110-114, 2001.
3. Rice T.W. Superficial esophageal carcinoma: is there a need for three-field lymphadenectomy? Lancet. 354: 792-794, 1999.
4. Sabik J.F., Rice T.W., Goldblum J.R., Koka A., Kirby T.J., Medendorp S.V., et al.: Superficial esophageal carcinoma. Ann. Thorac. Surg. 60: 896-902, 1995.
5. Rice T.W., Zuccaro G.Jr., Adelstein D.J., Rybicki L.A., Blackstone E.H., Goldblum J.R.: Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann. Thorac. Surg. 65: 787-792, 1998.
6. Muller J.D., Stein H.J., Oyang T., Natsugoe S., Faith M., Wemer M., et al.: Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction. Cancer 89: 1874-1882, 2000.
7. Hosch S., Kraaus J., Scheunemann P., Izbick J.R., Schneider C., Schumacher U., et al. Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer. Cancer Res. 60: 6836-6840, 2000.
8. Becker R.A., Chambers J.N., Wilks A.R.: The New S Language-A Programming Environment for Data Analysis and Graphics, AT&T Bell Laboratories, 1988.
9. Hayashi C.: On the prediction of phenomena from qualitative data on the quantification of qualitative data from the mathmatico-statistical point of view. Ann. inst. Stat. Math. 3: 69-98, 1952.
10. Sarbia M., Gabbert H.E.: Modern pathology: prognostic parameters in squamous cell carcinoma of esophagus. Recent Results Cancer Res. 155: 15-27, 2000.
11. Hirai T, Kuwahara M., Yoshida K., Osaki A., Toge T: The prognostic significance of p53, p21 (Waf 1/Cip 1), and cyclin D1 expression in esophageal cancer patients. Anticancer Res. 19(5C): 4587-4591, 1999.
12. Morisaki Y., Shima S., Yoshizumi Y., Sugiura Y., Tanaka S., Tamai S.: PCNA immuno staining combined with AgNOR staining in esophageal squamous cell carcinoma to identify patients with a poor prognosis. Surg. Today 25: 389-395, 1995.
13. Isono K., Uchida Y., Watanabe H., Tsurumaru M., Ando N., Funami Y., Ikeda H., Kato H., Matsubara T., Tachimori Y., Takubo K., Yoshida M., Guidelines for Clinical and Pathological Studies on Carcinoma of the Esophagus ninth edition, 2001.
14. Hiratsuka H., Miyakawa A., Nakamori K., Kido Y., Sunakawa H., Kohama G.: Multivariate analysis of occult lymph node metastasis as a prognostic indicator for patients with squamous cell carcinoma of the oral cavity. Cancer 80 (3): 351-356, 1997.
15. Morton D., Wen D., Cochran A.: Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy: an alternative to routine elective lymphadenectomy or "watch and wait." Surg. Oncol. Clin. N. Am. 1: 247-259, 1992.
16. Veronesi U., Paganelli G., Galimberti V., Viale G., Zurrida S., Bedoni M., et al.: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 349: 1864-1867, 1997.
17. Kitagawa Y., Ohgami M., Mukai M., Kubota T., Ando N., Watanabe M., et al.: Laparoscopic detection of sentinel lymph nodes in gastrointestinal cancer: a novel and minimally invasive approach. Ann. Surg. Oncol. 8(9 Suppl): 86S-9S, 2001.
18. Aikou T., Higashi H., Natsugoe S., Hokita S., Baba M., Tako S.: Can sentinel node navigation surgery reduce the extent of lymph node dissection in gastric cancer? Ann. Surg. Oncol. 8(9 suppl): 90S-3S, 2001.
19. Maruyama K., Sasako M., Kinoshita T., Sano T., Katai., H.: Can sentinel node biopsy indicate rational extent of lymphadenectomy in gastric cancer surgery? Fundamental and new information on lymph-node dissection. Langenbecks Arch. Surg. 384:149-157, 1999.
20. Ross D.T., Scherf U., Eisen M.B., Perou C.M., Rees C., Spellman P., et al.: Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 24: 227-235, 2000.